FIRM 2018
The Regenerative Medicine Toolbox; from Bench to Clinical Application
FIRM 2019
Â
Prof Fergal O'Brien
Bio-engineering and Regenerative Medicine, Royal College of Surgeons in Ireland
Dr Laura De Rosa
Head of Gene Therapy, Centre of Regenerative Medicine, University of Modena, Italy
Prof. Liam M Grover
Professor of Biomaterial Science, School of Chemical Engineering, University of Birmingham
Prof Sheila MacNeill
Professor of Tissue Engineering, University of Sheffield
Dr Lisa White
Regenerative Medicine and Cellular Therapy, University of Nottingham
Dr Vito Mennella
Associate Professor, University of Southampton
-
Scientific Impact - Dr Pep Pàmies (PhD), Nature Biomedical Engineering
-
IP and Commercialisation - Prof Sheila MacNeill and Prof Liam M Grover
-
Academic Career Insights - Prof Sheila MacNeill and Prof Fergal O'Brien
From Bench to Bedside:
How to Move your Research towards Commercialisation
FIRM 2018
Â
Dr Andrea Sass
Julius Wolff Institute, Charité – Universitätsmedizin, Berlin, Germany
Dr Sebastian Knöbel
Research and Development Manager, Miltenyi Biotec, Germany
Prof. Tim Woodfield
Professor of Regenerative Medicine, University of Otago Christchurch, New Zealand
Prof Elisabeth Engel
Professor of Biomaterials,
Technical University of Catalonia, Spain
Prof. Matteo Santin
Professor of Tissue Regeneration, University of Brighton, United Kingdom
Prof. Pedro Morouço
Professor of Biofabrication, Polytechnic Institute of Leiria, Portugal
-
Manufacturing Challenges - Dr Mark McCall (PhD), Loughborough University
-
Downstream Processing - Dr Karen Coopman (PhD), Loughborough University
-
Developing Effective Business Strategies - Dr Thomas Heathman (PhD), Hitachi Chemical Advanced Therapeutic Solutions (HCATS), formerly PCT
Clinical Translation in Regenerative Medicine
FIRM 2017
Â
Prof Stephen Badylak
Deputy Director at McGowan Institute, Pittsburgh, USA
Dr David Eglin
Principal Scientist at AO Foundation, Davos, Switzerland
Prof. Alvaro Mata
Director of the Institute of Bioengineering at Queen Mary University of London
Dr Robert Preti
CEO and President at PCT Cell Therapy, New Jersey, USA
Dr Ivan Wall
Senior Lecturer in Cell Therapy Bioprocessing at UCL, UK
Dr Eric Hill
Programme Director fo MSc Stem Cells and Regenerative Medicine at Aston University, UK
-
Imaging Tools for Regenerative Medicine - Prof. Erik Shapiro (PhD), Michigan State University
-
Careers in Academia - Karen Coopman (PhD), Loughborough University
-
Careers in Industry - Robert Preti (PhD), PCT Cell Therapy
-
The Nature of Scientific Publishing - Pep Pàmies (PhD), Nature Biomedical Engineering
The Life Cycle of Cell Therapy
FIRM 2016
Â
Dr Bo Kara
Head Process Development, Cell Gene Therapy Platform CMC, GSK
Dr Maria Pereira
Head of Research at Gecko Biomedical
Prof. Alvaro Mata
Director of the Institute of Bioengineering at Queen Mary University of London
Prof Erik Shapiro
Professor at Michigan State University, Michigan, USA
Prof Jillian Cornish
Professor at University of Auckland
Dr Robert J. Hariri
Co-Founder, President, Human Longevity Cellular Therapeutics
-
CV Clinic - 2016 keynote panel
-
How to write quality papers - Daniela Wilson (PhD), Radboud University
-
NC3Rs workshop - Katie Lidster (PhD), NC3Rs
Advances in Regenerative Medicine and Tissue Engineering
FIRM 2014
Â
Dr Robert Preti
CEO and President at PCT Cell Therapy, New Jersey, USA
Prof Paulo de Coppi
Head of Stem Cells and Regenerative Medicine at UCL, UK
Dr Alan Horner
Director Evidence Outcomes at Smith & Nephew. York, UK
Dr Kei Miyamoto
Postdoctoral Fellow at University of Cambridge, UK
Prof Katja Schenke-Layland
Head of Cell and Tissue Engineering at Fraunhofer Institute, Germany
-
Risk, Benefit and Uncertainty in Regenerative Medicine - David Brindley (PhD)
-
Communication, Collaboration and Innovation Workshop - Jamie Cleaver (PhD)
-
Imaging Tools for Regenerative Medicine - Prof. Erik Shapiro (PhD), Michigan State University
